Financhill
Back

Organon & Quote, Financials, Valuation and Earnings

Organon & Price Quote

$14.97
+0.24 (+1.63%)
(Updated: November 21, 2024 at 2:15 PM ET)

Organon & Key Stats

Sell
12
Organon & (OGN) is a Sell

Day range:
$14.45 - $14.78
52-week range:
$10.84 - $23.10
Dividend yield:
7.42%
P/E ratio:
3.78
P/S ratio:
0.61
P/B ratio:
7.89%

Volume:
2.3M
Avg. volume:
2.8M
1-year change:
31.64%
Market cap:
$3.9B
Revenue:
$6.3B
EPS:
$5.04

How Much Does Organon & Make?

  • How Much Are Organon &'s Sales Annually?
    OGN Revenues are $6.3B
  • How Much Profit Does Organon &'s Make A Year?
    OGN net income is $1B

Is Organon & Growing As A Company?

  • What Is Organon &'s Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is Organon &'s EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 5%

Organon & Stock Price Performance

  • Did Organon & Stock Go Up Last Month?
    Organon & share price went down by -16.35% last month
  • Did OGN's Share Price Rise Over The Last Year?
    OGN share price rose by 31.64% over the past 1 year

What Is Organon & 52-Week High & Low?

  • What Is Organon &’s 52-Week High Share Price?
    Organon & has traded as high as $23.10 over the past 52 weeks
  • What Is Organon &’s 52-Week Low Share Price?
    Organon & has traded as low as $10.84 over the past 52 weeks

Organon & Price To Free Cash Flow

Is It Risky To Buy Organon &?

  • How Much Debt Does Organon & Have?
    Total long term debt quarterly is $8.7B
  • How Much Cash Does Organon & Have?
    Cash and short term investments quarterly total is $763M
  • What Is Organon &’s Book Value Per Share?
    Book value per share is 1.91

Is Organon & Cash Flow Positive?

  • What Is OGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $946M
  • What Is Organon &’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$363M
  • What Is Organon &’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$298M

Organon & Return On Invested Capital

  • Is Management Doing A Good Job?
    OGN return on invested capital is 14.93%
  • What Is Organon & Return On Assets?
    ROA measures how assets are converting to revenues and is 10.87%
  • What Is OGN Return On Equity?
    ROE is a measure of profitability and is 25019.23%

Organon & Earnings Date & Stock Price

  • What Is Organon &'s Stock Price Today?
    A single share of OGN can be purchased today for 14.73
  • What Is Organon &’s Stock Symbol?
    Organon & trades on the nyse under the ticker symbol: OGN
  • When Is Organon &’s Next Earnings Date?
    The next quarterly earnings date for Organon & is scheduled on February 14, 2025
  • When Is OGN's next ex-dividend date?
    Organon &'s next ex-dividend date is November 12, 2024
  • How To Buy Organon & Stock?
    You can buy Organon & shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Organon & Competitors

  • Who Are Organon &'s Competitors?
    Below is a list of companies who compete with Organon & or are related in some way:
    • Applied Therapeutics Inc (APLT)
    • Eli Lilly and Co (LLY)
    • ResMed Inc (RMD)
    • Sage Therapeutics Inc (SAGE)
    • TG Therapeutics Inc (TGTX)

Organon & Dividend Yield

  • What Is OGN Dividend Yield?
    Organon &’s dividend yield currently is 7.42%
  • What Is Organon &’s Payout Ratio?
    Organon &’s payout ratio is 22.75%
  • When Did Organon & Last Pay A Dividend?
    The latest dividend pay date is November 21, 2024
  • What Is Organon &’s Dividend Per Share?
    Organon & pays a dividend of $0.28 per share

Organon & Analyst Estimates

YoY Growth Past Surprise
EPS: 500% -3.71%
Revenue: 4.15% 1.15%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 22.38
Upside from Last Price: 51.9%

Major Shareholders

  • How many OGN shares are owned by institutional investors?
    292.5M OGN shares are owned by institutional investors
  • How many OGN shares are owned by insiders?
    570.3K OGN shares are owned by insiders